Stay updated on SGN-PDL1V in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.

Latest updates to the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Gastric cancer as a study condition. Removed government funding lapse notice and updated page revision to v3.4.2.SummaryDifference0.3%

- Check21 days agoChange DetectedThe page now displays a government-funding lapse notice about possible delays and updates the site revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded a Show glossary option and new meta-information fields: Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed or replaced items include Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. This appears to be an internal site version update with no changes to the study details or content.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section now lists 62 sites (up from 61). It expands recruitment across multiple regions, including new U.S. states and international locations such as Canada, China, Belgium, France, Germany, Italy, Japan, the Netherlands, Spain, and the United Kingdom.SummaryDifference2%

- Check77 days agoChange DetectedNew locations were added (e.g., University Health Network in Toronto; The University of Iowa; UC Irvine Health – Chao Family Cancer Center; NEXT Virginia in San Antonio) and several locations were removed (including Wuhan, China and two London sites), with the total number of locations updated to 61.SummaryDifference1%

Stay in the know with updates to SGN-PDL1V in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.